NOTV vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

NOTV

44.8
AI Score
VS
NOTV Wins

CDNA

32.0
AI Score

Investment Advisor Scores

NOTV

45score
Recommendation
HOLD

CDNA

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NOTV CDNA Winner
Forward P/E 3.7216 156.25 NOTV
PEG Ratio 0 -0.12 Tie
Revenue Growth -5.4% 52.2% CDNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.8/100 32.0/100 NOTV
Profit Margin -17.1% 24.2% CDNA
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NOTV

Relative Price Performance (Last 90 Days)

NOTV 1M: -72.8% · 3M: -79.5% CDNA 1M: +35.4% · 3M: +131.1%

Current Technical Phase

NOTV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.9%), weak momentum, RSI 32

RSI (14): 31.9 · Price: $0.08

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 81.3 · Price: $67.15

Fundamentals Snapshot

Metric NOTV CDNA
Market Cap — —
Forward P/E 0.0 52.1
Trailing P/E — 31.8
Revenue (TTM) — —
Revenue Growth -0.1% 0.5%
Gross Margin 0.2% 0.7%
Operating Margin -0.2% 0.0%
EPS -2.48 2.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NOTV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.